Sort
39,280 grants matching “leukemia”
Tumor microenvironment in CLL and MCL: pathogenesis, targets, and therapy
$1,276,483Adrian U Wiestner · National Heart, Lung, And Blood Institute · ZIA · FY2014 · HL
IL-2 Family Cytokines and Receptors-- Mechanisms of Regulation & Action
$1,276,309Warren J Leonard · National Heart, Lung, And Blood Institute · ZIA · FY2014 · HL
Regulation And Function Of Retroelements
$1,275,554Henry L. Levin · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · Z01 · FY2008 · HD
BIOLOGY AND TRANSPLANTATION OF THE HUMAN STEM CELL
$1,275,301University Of Minnesota Twin Cities · P01 · FY2000 · CA
OSU as a Network Lead Academic Participating Site for the NCI NCTN
$1,274,922Claire F Verschraegen · Ohio State University · UG1 · FY2024 · CA
Sphingolipids in Cancer Biology and Therapy
$1,273,456Yusuf Awni Hannun · State University New York Stony Brook · P01 · FY2022 · CA
Cancer Epigenetics Deregulation of Chromatin templated Processes
$1,273,204Tom W Muir · Rockefeller University · RC2 · FY2010 · CA
DLK1 as a novel target for Down syndrome myeloid leukemia
$1,273,073Anilkumar Gopalakrishnapillai · Nemours Children'S Hospital, Delaware · R01 · FY2025 · CA
Mechanisms of axon guidance during development
$1,271,308Edward Giniger · National Institute Of Neurological Disorders And Stroke · ZIA · FY2009 · NS
Transplant Models
$1,271,094Ronald Gress · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Systems Biology of Bone Marrow Failure and MDS for Precision Medicine
$1,271,028Akiko Shimamura · Boston Children'S Hospital · RC2 · FY2023 · DK
Systems Biology of Bone Marrow Failure and MDS for Precision Medicine
$1,271,028Akiko Shimamura · Boston Children'S Hospital · RC2 · FY2022 · DK
Systems Biology of Bone Marrow Failure and MDS for Precision Medicine
$1,271,028Akiko Shimamura · Boston Children'S Hospital · RC2 · FY2021 · DK
THERAPY OF AML
$1,270,463University Of Texas Md Anderson Can Ctr · P01 · FY2000 · CA
Analysis of Pathways that Suppress or Accelerate Premalignant Progression and Ma
$1,269,850Stuart H. Yuspa · Basic Sciences · Z01 · FY2007 · CA
Immunobiology and immunotherapy of leukemia
$1,267,777Austin J Barrett · National Heart, Lung, And Blood Institute · ZIA · FY2011 · HL
Characterization and improvement of graft versus leukemia effects
$1,267,777Austin J Barrett · National Heart, Lung, And Blood Institute · ZIA · FY2011 · HL
Customized stem cells for clinical application in blood disorders
$1,267,717George Q Daley · Boston Children'S Hospital · R24 · FY2012 · DK
Mechanisms of Mammalian Epigenome Reprogramming
$1,267,478Todd Scott Macfarlan · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2018 · HD
BMT Survivor Study-2 (BMTSS-2)
$1,266,852Smita Bhatia · University Of Alabama At Birmingham · U01 · FY2023 · CA
Genetic Aspects Of Viral Oncogenesis In Inbred Strains and Wild Mouse Species
$1,266,482Christine Kozak · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Chromatin and epigenetic memory
$1,266,294Keiko Ozato · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2023 · HD
Preclinical Mouse Models of Thyroid Cancer
$1,261,890Sheue-Yann Cheng · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Center
$1,261,445Sylvia Katina Plevritis · Stanford University · U54 · FY2013 · CA
Kinetic Biomarker for CLL Prognosis
$1,261,275Kinemed, Inc. · R44 · FY2005 · CA